For questions about BMS medicines during this time please call 1-800-721-8909.
IDHIFA® Wallet Cards
DOCTOR DISCUSSION GUIDE
This resource includes useful tools that you can use to prep for doctor’s visits. In it you’ll find:
CELGENE PATIENT SUPPORT® (CPS®)
During your journey with IDHIFA®, CPS® can provide you with a local Specialist who can:
Not sure where to start? No problem.
Answer the following questions to receive a personalized list of IDHIFA® resources
Are you a patient or a caregiver?
Do you need more information from your doctor?
Do you need help paying for IDHIFA®?
Are you unsure about the common terms of AML?
Are you familiar with the potential side effect of IDHIFA®, differentiation syndrome?
Use this page as a reference for any of the terms that may be difficult, or difficult to remember, during treatment. It’s also a useful guide for you to give to your caregiver, friends, and family, as they go through this journey with you.
An illness that will progress quickly if left untreated
Short for acute myeloid leukemia, a blood cancer of the bone marrow
Immature blood cells that are not usually found in the blood
The soft interior of the bones where new blood cells are created
When there is a low number of healthy cells in the body
Of, or relating to, blood
Isocitrate dehydrogenase-2; the mutated enzyme that IDHIFA® targets through inhibition
An abnormal change within a cell
Help prevent bleeding caused by cuts and bruises
Red blood cells
Carry oxygen from the lungs to all cells in the body
Relapsed or refractory
The AML has not responded to any attempts at treatment
The signs and symptoms of AML have returned after a period of response to treatment
The signs and symptoms of AML decrease or go away entirely
White blood cells
Help the body fight infections. They are a crucial part of the body’s immune system
Are you a caregiver? Explore additional resources to help you care for your loved ones.VISIT OUR CAREGIVER PAGE
Please choose an option:Visit Healthcare Professional Site
The information contained in this website is intended for U.S. audiences only.